Home CV Biosketch Publications

Patricia M. Danzon, Ph.D.
Health Care Management Department
The Wharton School
University of Pennsylvania

Journal Articles

 

 

"Prices and Availability of Biopharmaceuticals: An International Comparison." With Michael Furukawa. Health Affairs,, 25(5): 1353-1362, Sep/Oct 2006.
"Why Sole Supplier Vaccine Markets May be Here to Stay." With Nuno Pereira. Health Affairs,, 24(3): 694-696, May/June 2005.
"Vaccine Supply: A Cross-National Perspective." With Nuno Pereira and Sapna Tejwani. Health Affairs, 24(3): 706-717, May/June 2005.
“Alternative Strategies for Medicare Payment of Outpatient Prescription Drugs - Part B and Beyond." With Gail R. Wilensky and Kathleen E. Means. American J. of Managed Care, 11(3): 173-180, 2005.
“The Impact of Price Regulation on the Launch Delay of New Drugs.” With Y. Richard Wang and Liang Wang. Health Economics, 14(3), 2005.
"Productivity in Pharmaceutical-Biotechnology R&D: The Role of Experience and Alliances" With Sean Nicholson and Nuno Sousa Pereira. J. of Health Economics, 24(2): 317-339, 2005.
“Biotech-Pharma Alliances as a Signal of Asset and Firm Quality.” With Sean Nicholson and Jeff McCulloch. J. of Business, January 2002.
"From the Field: Closing the Doughnut Hole: No Easy Answers." Health Affairs Web Exclusive, July 2004. http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.405v1. Last accessed September 22, 2004.
"Prices and Availability of Pharmaceuticals: Evidence From Nine Countries." With Michael F. Furukawa. Health Affairs Web Exclusive. October 2003. http://www.healthaffairs.org/WebExclusives/Danzon_Web_Excl_102903.htm. Last accessed October 29, 2003.
"Differential Pricing for Pharmaceuticals: Reconciling Access, R&D, and Patents." With Adrian Towse. International Journal of Health Care Finance and Economics, 3: 183-205, 2003.
"Effects of Tiered Co-Payments for Pharmaceuticals." With Tom Rector and Mark Pauly. Medical Care, 41(3), March 2003.
"Health Insurance and the Growth of Pharmaceutical Expenditures." With Mark V. Pauly. J. Legal Studies, XLV(2) Pt. 2. (October 2002): 587-613.
"Welfare Effects of Supplementary Insurance: A Comment" J. Health Economics 21 (5): 923-926. 2002.
"The Economics of Gene Therapy and Pharmacogenetics." With Adrian K. Towse. Value in Health 5(1): 5-13, 2002.
"A General Model of the Impact of Absenteeism on Employers and Employees," with Mark Pauly et al. Health Economics, 11(3): 221-232, 2002.
"Insurance and New Technology: From the Hospital to Drugstore." 2001. With Mark Pauly. Health Affairs 20 (5): 86-100.
"Workers' Compensation Rate Regulation: How Price Controls Increase Costs." 2001. With Scott Harrington. J. Law and Economics. 44:1-36.
"Making Sense of Drug Prices." 2000. Regulation 23(1): 56-63
"Cross-National Price Differences for Pharmaceuticals: How Large and Why?" 2000. With LiWei Chao. J. Health Economics. 19:159-195.
"Does Regulation Drive out Competition in the Pharmaceutical Industry?" 2000. With LiWei Chao. J. Law and Economics. 43(2): 311-357. Reprinted in "Law, Medicine, and Medical Technology: Cases and Materials" Eds. Lars Noah and Barbara A. Noah (forthcoming, Foundation Press, 2002).
"The Genomic Revolution: Is the Real Risk Under-investment Rather than Bankrupt Health Care Systems?" with Adrian K. Towse. J. Health Services Research and Policy, 5(4), October 2000.
“Rate Regulation, Safety Incentives and Loss Growth in Workers’ Compensation Insurance.” 1999. With Scott Harrington. Journal of Business 73:569.
"Medical Negligence and the NHS: An Economic Analysis." 1999. With Adrian Towse. Health Economics 8:93-101
"The Economics of Parallel Trade." PharmacoEconomics. March 1998. 13(3):293-304.
"Competition in the Off-Patent Sector: The US Experience." 1998. Pharma Pricing Review 3(3)
"Competition for Off-Patent Pharmaceuticals: Lessons from the US " 1998. EuroHealth. 4(2):24-26.
"International Price Comparisons for Pharmaceuticals: Measurement and Policy Issues." 1998. With Jeong Kim. PharmacoEconomics. 14(1):115-128.
"Price Differentials for Medicines Between and Within Countries." European Pharmaceutical Law Notebooks. III(8) 1997.

"Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU." International J. of the Economics of Business. 4(3):301-321, 1997
"Price, Financial Quality, and Capital Flows in Insurance Markets." with J. David Cummins. Journal of Financial Intermediation. 6:3-38. January 1997.

"Tort Liability: A Minefield for Managed Care?" Journal of Legal Studies. XXVI (2) Part 2. June 1997.

"Consolidation is a Tonic for Health Care Providers." National Law Journal, September 18, 1995.

"Merger Mania: An Analysis," Health Systems Review. 27(6), 1994.

"Health Care Reform: An International Perspective," with Grant D.H. Maclaine, Australian Economic Review, 1994.

"Price Cutting in Liability Insurance Markets," with Scott E. Harrington, Journal of Business, 67(4) 1994.
"The Swedish Patient Compensation System: Myths and Realities," International Review of Law and Economics, (1994) 14.
"Tort Reform: The Case of Medical Malpractice," Oxford Review of Economic Papers, 10(1), 1994.
"The Swedish Patient Compensation System: Lessons for the U.S." Journal of Legal Medicine, 15(2), June 1994.
"The Economic Implications of Public Disability Insurance in the U.S." Journal of Labor Economics. 11 (1) Part 2 January 1993
"Liability for Medical Malpractice," Journal of Economic Perspectives, Summer 1991.
"A Plan for Responsible National Health Insurance," with Mark Pauly, Paul Feldstein and John Hoff. Health Affairs, Spring 1991.
"The Effects of Malpractice Litigation on Physicians' Fees and Incomes," with Mark V. Pauly and Raynard S. Kington, American Economic Review, May 1990.
"Alternative Liability Regimes for Medical Injuries," Geneva Papers on Risk and Insurance, January 1990.

"Compensation for Occupational Disease: Evaluating the Options," Journal of Risk and Insurance, LIV (2), June, 1987.
"The Frequency and Severity of Medical Malpractice Claims: New Evidence," Law and Contemporary Problems, 49 (2), Spring, 1986.
"Liability and Liability Insurance for Medical Malpractice," Journal of Health Economics (4) 1985. Reprinted in Economic of Tort Law. Edited by Alan O. Sykes. Edward Elgar Press 2007.
"Comment on Landes and Posner, 'A Positive Economic Analysis of Products Liability,'" Journal of Legal Studies, December, 1985.
"Separation of the Redistributive and Allocative Functions of Government: A Public Choice Perspective," with Marilyn R. Flowers, Journal of Public Economics, 1984. Reprinted in The Foundations of 20th Century Economics: Landmark Papers Selected by Nobel Laureates; James Buchanan Edward Elgar Press.
"Tort Reform and the Role of Government in Private Insurance Markets," Journal of Legal Studies, August 1984.
"The Frequency and Severity of Medical Malpractice Claims," Journal of Law and Economics, April 1984.
"Factors Affecting Laboratory Test Use and Prices," with Willard G. Manning, Jr. and M. Susan Marquis, Health Care Financing Review, 1983.
"Settlement Out of Court: The Disposition of Medical Malpractice Claims," with Lee A. Lillard, Journal of Legal Studies, June 1983.
"An Economic Analysis of the Medical Malpractice System," Behavioral Sciences and the Law, 1(1), 1983.
"Hospital "Profits": The Effects of Reimbursement Policies," Journal of Health Economics (1), 1982.
"Contingent Fees for Personal Injury Litigation," Bell Journal of Economics, 11(3): 2691-279, Spring 1983.
"Economic Incentives to Order Lab Tests: Theory and Evidence," Socioeconomic Issues in Health, June 1980.
"Comment on Victor R. Fuchs, "From Bismarck to Woodcock: The Irrational Pursuit of National Health Insurance,"" Journal of Law and Economics, August 1976.

"An Economic Analysis of Eminent Domain," Journal of Political Economy 84(3): 473-498, June 1976.

 

Home CV Biosketch Publications